Oriol Roca to Humans
This is a "connection" page, showing publications Oriol Roca has written about Humans.
Connection Strength
0.059
-
Early Tracheostomy for Managing ICU Capacity During the COVID-19 Outbreak: A Propensity-Matched Cohort Study. Chest. 2022 01; 161(1):121-129.
Score: 0.008
-
Nasal high-flow oxygen therapy in COVID-19 patients does not cause environmental surface contamination. J Hosp Infect. 2021 10; 116:103-105.
Score: 0.008
-
Airway Alterations and Diffuse Alveolar Damage in Acute Respiratory Distress Syndrome: Is There Any Association? Arch Bronconeumol (Engl Ed). 2019 Jan; 55(1):3-4.
Score: 0.006
-
Hypoxemic Patients With Bilateral Infiltrates Treated With High-Flow Nasal Cannula Present a Similar Pattern of Biomarkers of Inflammation and Injury to Acute Respiratory Distress Syndrome Patients. Crit Care Med. 2017 Nov; 45(11):1845-1853.
Score: 0.006
-
High-Flow Nasal Cannula Meta-Analysis: Do Not Mix Apples and Oranges! Crit Care Med. 2017 02; 45(2):e244.
Score: 0.006
-
Awake prone positioning for COVID-19 acute hypoxaemic respiratory failure: a randomised, controlled, multinational, open-label meta-trial. Lancet Respir Med. 2021 12; 9(12):1387-1395.
Score: 0.002
-
Risk factors and outcomes of ventilator-associated pneumonia in COVID-19 patients: a propensity score matched analysis. Crit Care. 2021 07 06; 25(1):235.
Score: 0.002
-
Awake Proning as an Adjunctive Therapy for Refractory Hypoxemia in Non-Intubated Patients with COVID-19 Acute Respiratory Failure: Guidance from an International Group of Healthcare Workers. Am J Trop Med Hyg. 2021 Mar 11; 104(5):1676-1686.
Score: 0.002
-
Safety, diagnostic, and therapeutic value of flexible bronchoscopy in critically ill COVID-19 patients. Can J Anaesth. 2021 03; 68(3):434-435.
Score: 0.002
-
Awake prone positioning of hypoxaemic patients with COVID-19: protocol for a randomised controlled open-label superiority meta-trial. BMJ Open. 2020 11 11; 10(11):e041520.
Score: 0.002
-
COVID-19-related and non-COVID-related acute respiratory distress syndrome: two sides of the same coin? Intensive Care Med. 2020 12; 46(12):2197-2199.
Score: 0.002
-
Updated guidance on the management of COVID-19: from an American Thoracic Society/European Respiratory Society coordinated International Task Force (29 July 2020). Eur Respir Rev. 2020 Sep 30; 29(157).
Score: 0.002
-
Vitamin C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome. Crit Care. 2020 08 26; 24(1):522.
Score: 0.002
-
Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure. Intensive Care Med. 2020 10; 46(10):1924-1926.
Score: 0.002
-
Dynamic assessment of the ROX index during nasal high flow for early identification of non-responders. J Crit Care. 2020 08; 58:130-131.
Score: 0.002
-
Increasing support by nasal high flow acutely modifies the ROX index in hypoxemic patients: A physiologic study. J Crit Care. 2019 10; 53:183-185.
Score: 0.002
-
Pressure support ventilation + sigh in acute hypoxemic respiratory failure patients: study protocol for a pilot randomized controlled trial, the PROTECTION trial. Trials. 2018 Aug 29; 19(1):460.
Score: 0.002
-
A prospective international observational prevalence study on prone positioning of ARDS patients: the APRONET (ARDS Prone Position Network) study. Intensive Care Med. 2018 01; 44(1):22-37.
Score: 0.001
-
Respiratory support therapy after extubation: Who and how? Med Intensiva (Engl Ed). 2018 May; 42(4):255-257.
Score: 0.001
-
High-flow nasal cannula support therapy: new insights and improving performance. Crit Care. 2017 Mar 21; 21(1):62.
Score: 0.001